Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER MODELS

The therapy escapes of small-cell lung cancer

Nature Cancer volume 1, pages 374–375 (2020)Cite this article

Subjects

Small-cell lung cancer rapidly develops resistance to standard-of-care therapy. Two papers now establish xenograft models derived from patient-derived circulating tumor cells and show that initially homogeneous, chemoresponsive tumors rapidly recur as heterogeneous drug-refractory disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Modeling SCLC response to therapy using single-cell sequencing and patient-derived CDXs.

References

  1. Rudin, C. M. et al. Nat. Rev. Cancer 19, 289–297 (2019).

    Article  CAS  Google Scholar 

  2. Stewart, C. A. et al. Nat. Cancer https://doi.org/10.1038/s43018-019-0020-z (2020).

    Article  Google Scholar 

  3. Simpson, K. L. et al. Nat. Cancer https://doi.org/10.1038/s43018-020-0046-2 (2020).

    Article  Google Scholar 

  4. Hodgkinson, C. L. et al. Nat. Med. 20, 897–903 (2014).

    Article  CAS  Google Scholar 

  5. Lallo, A. et al. Clin. Cancer Res. 24, 5153–5164 (2018).

    CAS  PubMed  Google Scholar 

  6. Drapkin, B. J. et al. Cancer Discov. 8, 600–615 (2018).

    Article  CAS  Google Scholar 

  7. Gazdar, A. F. Oncogene 28, S24–S31 (2009).

    Article  CAS  Google Scholar 

  8. George, J. et al. Nature 524, 47–53 (2015).

    Article  CAS  Google Scholar 

  9. Mollaoglu, G. et al. Cancer Cell 31, 270–285 (2017).

    Article  CAS  Google Scholar 

  10. Denny, S. K. et al. Cell 166, 328–342 (2016).

    Article  CAS  Google Scholar 

  11. Calbo, J. et al. Cancer Cell 19, 244–256 (2011).

    Article  CAS  Google Scholar 

  12. Lim, J. S. et al. Nature 545, 360–364 (2017).

    Article  CAS  Google Scholar 

  13. McNair, C. et al. J. Clin. Invest. 128, 341–358 (2018).

    Article  Google Scholar 

  14. Zocchi, L. et al. Oncogenesis 9, 25 (2020).

    Article  CAS  Google Scholar 

  15. Ishak, C. A. et al. Mol. Cell 64, 1074–1087 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncode Institute, Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands

    Anton Berns

Authors
  1. Anton Berns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anton Berns.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berns, A. The therapy escapes of small-cell lung cancer. Nat Cancer 1, 374–375 (2020). https://doi.org/10.1038/s43018-020-0058-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-020-0058-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer